Gilead Sciences, Inc.
Close on Nov 2, 2026Market cap $211.20BP/E –Yield 1.86%
Gilead Sciences Other equity method investments by Year
Other equity method investments (incl. Assembly Biosciences) — Fair value carrying amount ($M) ($M)
Gilead Sciences Other equity method investments: $183M in FY2025, up 245.3% from a year earlier.
Where the FY2025 figure comes from
“|| Other equity method investments – fair value option (1) | 171 | 183”
Source: Form 10-Q (gild-20260630.htm, filed 2026-08-06) ↗
Reported in Form 10-Q / 10-K Note 4 Equity Securities.
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Other equity method investments (incl. Assembly Biosciences) — Fair value carrying amount ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 183 | +245.3% | Form 10-Q (gild-20260630.htm, filed 2026-08-06) ↗ |
| FY2024 | Dec 31, 2024 | 53 | – | Form 10-K (gild-20251231.htm, filed 2026-02-24) ↗ |
Cite this data
StockData. (2026). Gilead Sciences Other equity method investments ($M), annual FY2024–FY2025 [Data set]. Compiled from Gilead Sciences SEC filings and investor materials. https://stockdatahq.com/stocks/gild/kpis/eq-inv-other-fvo
See every metric in the Gilead Sciences KPI table. Data updated Oct 29, 2026.